There are currently more than 150 different COVID-19 vaccines under development. Of these, more than 50 have reached human trials, and seven have been approved for emergency or full use in parts of Europe, North America, and Asia. In the United States, two vaccines—one from the biotechnology company, Moderna and the other from drug giant Pfizer—have been granted an Emergency Use Authorization (EUA) from the FDA. To read the full story.
Recent Posts
- Join NJ ACTS Biostatistics, Epidemiology, Research Design (BERD) Workshop Series on June 19th
- NJIT Study Probes Genetic ‘Smoking Gun,’ Health Risks of Vaping Among Gen Z.
- Measles cases seem to be slowing down in the US. What’s behind it?
- Rutgers-Newark Launches Institute on Improving Communities Through AI and Interdisciplinary Data Work.
- Here’s how the proposed deep cuts to Medicaid would affect N.J.
Categories
- Community (2,269)
- Covid (986)
- CTO Events (6)
- News (2,890)
- Pilots (21)